ArticleJPRAS open2026
Material type versus defect size in adult cranioplasty: a multi-institutional analysis of 30-day outcomes and risk prediction modeling.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The optimal cranioplasty material remains controversial in the context of defect size and patient risk. We analyzed multi-institutional data over 13 years to evaluate the interaction between material type and defect size. Methods: We performed a retrospective cohort analysis of adult cranioplasty patients in the ACS-NSQIP (2011-2023), stratifying by material type (autograft vs. alloplastic) and defect size (≤5 cm vs. >5 cm). The primary outcome was any 30-day complication. Multivariable logistic regression adjusting for 21 covariates, interaction analyses, and machine learning models were applied. Results: Among 3894 patients, 88% underwent autograft and 12% alloplastic cranioplasty. The 30-day complication rate was 22%, with no significant difference between material types ( Conclusion: Material type is not an independent predictor of short-term complications following cranioplasty, regardless of defect size or patient risk profile. Larger defects are associated with increased morbidity, but alloplastic materials offer significant operative efficiency without compromising short-term perioperative safety. Prospective studies with extended follow-up stratified by alloplastic subtype are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.